|
Vaccine Detail
N. meningitidis ExbB Protein Vaccine |
Vaccine Information |
- Vaccine Name: N. meningitidis ExbB Protein Vaccine
- Target Pathogen: Neisseria meningitidis
- Target Disease: Meningitis
- Vaccine Ontology ID: VO_0004011
- Type: Subunit vaccine
- Status: Research
- ExbB
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Adjuvant:
- Immunization Route: Subcutaneous injection
|
Host Response |
Mouse Response
- Host Strain: BALB/c
- Vaccination Protocol: To examine the protective efficacy of recombinant proteins, adult mice (6-week-old, female BALB/c animals, 35 per group) were immunised on days 1 and 21 with 25 μg of antigen given by subcutaneous (s.c.) injection. Each protein was mixed with Freund's incomplete adjuvant (50% v/v) prior to administration. Mice in control groups were immunised with adjuvant alone or recombinant homologous PorA prior to challenge (Sun et al., 2005).
- Challenge Protocol: 28 days after immunization, animals were challenged with live bacteria at either a high (10^7 CFU, 15 mice) or low (10^6 CFU, 15 mice) dose of MC58 (Sun et al., 2005).
- Efficacy: ExbB, which is required for iron acquisition, elicited protective immunity and was able to protect mice from bacterial challenge (Sun et al., 2005).
|
References |
Sun et al., 2005: Sun Y, Li Y, Exley RM, Winterbotham M, Ison C, Smith H, Tang CM. Identification of novel antigens that protect against systemic meningococcal infection. Vaccine. 2005; 23(32); 4136-4141. [PubMed: 15964482].
|
|